Healthcare provider profile · identity verified

Alfred Jean, FNP

Nurse Practitioner · BRONX, NY · NPI 1003288762

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	194	49
Omeprazole	Omeprazole	152	33
Amlodipine Besylate	Amlodipine Besylate	135	38
Gabapentin	Gabapentin	134	27
Metformin Hcl	Metformin Hcl	127	33
Nystatin	Nystatin	96	20
Ammonium Lactate	Ammonium Lactate	87	17
Mirtazapine	Mirtazapine	87	18
Metoprolol Succinate	Metoprolol Succinate	86	21
Donepezil Hcl	Donepezil Hcl	78	16
Albuterol Sulfate Hfa	Albuterol Sulfate	76	18
Levothyroxine Sodium	Levothyroxine Sodium	74	17
Tamsulosin Hcl	Tamsulosin Hcl	74	17
Famotidine	Famotidine	71	13
Meclizine Hcl	Meclizine Hcl	69	19
Quetiapine Fumarate	Quetiapine Fumarate	68	15
Losartan Potassium	Losartan Potassium	64	19
Furosemide	Furosemide	60	15
Torsemide	Torsemide	58	11
Ibuprofen	Ibuprofen	57	16
Januvia	Sitagliptin Phosphate	50	11
Lisinopril	Lisinopril	49	15
Rosuvastatin Calcium	Rosuvastatin Calcium	49	13
Eliquis	Apixaban	48	15
Clopidogrel	Clopidogrel Bisulfate	47	11
Montelukast Sodium	Montelukast Sodium	46	suppressed
Memantine Hcl	Memantine Hcl	44	11
Silver Sulfadiazine	Silver Sulfadiazine	44	12
Vitamin D2	Ergocalciferol (Vitamin D2)	44	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	42	suppressed
Carvedilol	Carvedilol	39	suppressed
Fluticasone Propionate	Fluticasone Propionate	37	12
Linzess	Linaclotide	34	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	34	suppressed
Trazodone Hcl	Trazodone Hcl	31	suppressed
Labetalol Hcl	Labetalol Hcl	29	suppressed
Latanoprost	Latanoprost	29	suppressed
Sertraline Hcl	Sertraline Hcl	29	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Clonidine	Clonidine	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	suppressed
Simvastatin	Simvastatin	25	suppressed
Naproxen	Naproxen	24	suppressed
Finasteride	Finasteride	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Glipizide	Glipizide	21	suppressed
Megestrol Acetate	Megestrol Acetate	21	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	19	suppressed
Amantadine	Amantadine Hcl	19	suppressed
Lactulose	Lactulose	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Loperamide	Loperamide Hcl	19	suppressed
Ssd	Silver Sulfadiazine	19	suppressed
Meloxicam	Meloxicam	18	suppressed
Nyamyc	Nystatin	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Duloxetine Hcl	Duloxetine Hcl	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Ozempic	Semaglutide	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	15	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Santyl	Collagenase Clostridium Hist.	14	suppressed
Atenolol	Atenolol	13	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Nystop	Nystatin	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Valsartan	Valsartan	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Dilantin	Phenytoin Sodium Extended	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Prednisone	Prednisone	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error